Clinical Trial Update: Fruquintinib Combined With Standard Chemotherapy Versus Standard Chemotherapy as First-line Treatment for Advanced pMMR Endometrial Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Fruquintinib in combination with standard chemotherapy versus standard chemotherapy alone as first-line treatment for advanced profic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Fruquintinib (fruquintinib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Endometrial Cancer | Phase 2 | Status: NOT_YET_RECRUITING